Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, remains a significant health concern worldwide, particularly in developing countries. Despite advances in healthcare, effective management of enteric fever in clinical practice remains challenging. This article aims to explore the most effective strategies for managing this condition.
Rapid and accurate diagnosis is the cornerstone of effective management. Blood culture remains the gold standard for diagnosis, but its sensitivity can be limited. Newer diagnostic techniques, such as PCR and serological tests, offer promising alternatives.
Antibiotic therapy is the mainstay of treatment for enteric fever. However, the increasing prevalence of multidrug-resistant strains requires careful antibiotic selection. Fluoroquinolones, third-generation cephalosporins, and azithromycin are currently the drugs of choice.
Vaccination is a crucial preventive measure. Two vaccines - the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine - are currently available. However, their efficacy varies, and they are not suitable for all populations. Continued research into more effective vaccines is needed.
Public health measures, such as improved sanitation and safe drinking water, play a significant role in preventing enteric fever. These measures are particularly important in endemic areas where antibiotic resistance is high.
Effective management of enteric fever requires a multifaceted approach, including accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Clinicians must stay abreast of the latest developments in diagnosis and treatment, while public health initiatives must focus on prevention. As antibiotic resistance continues to rise, the need for new treatment strategies and vaccines becomes increasingly urgent.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation